Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Roivant Sciences Ltd (ROIV)

Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Roivant Sciences Ltd 7th Floor 50 Broadway LONDON X0 SW1H 0DB GBR

https://roivant.com Employees: 750 P: 44-20-7400-3347

Sector:

Medical

Description:

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 21,256,320
Enterprise Value, $K 18,540,910
Shares Outstanding, K 715,701
Float, K 638,405
% Float 89.20%
Short Interest, K 22,266
Short Float 3.11%
Days to Cover 2.43
Short Volume Ratio 0.23
% of Insider Shareholders 10.80%
% of Institutional Shareholders 64.76%

Financials:

Annual Sales, $ 29,050 K
Annual Net Income, $ -171,980 K
Last Quarter Sales, $ 2,000 K
Last Quarter Net Income, $ -265,890 K
EBIT, $ -1,197 M
EBITDA, $ -1,183 M

Growth:

1-Year Return 180.72%
3-Year Return 241.38%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.38 on 02/06/26
Next Earnings Date 06/04/26
Earnings Per Share ttm -1.37
EPS Growth vs. Prev Qtr 10.00%
EPS Growth vs. Prev Year -80.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ROIV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -19.04%
Return-on-Assets % -18.15%
Profit Margin % -592.01%
Debt/Equity 0.00
Price/Sales 727.45
Price/Cash Flow N/A
Price/Book 4.11
Book Value/Share 7.01
Interest Coverage -0.42
60-Month Beta 1.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar